These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 7828296)
21. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial. Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S J Am Coll Cardiol; 2004 Jun; 43(12):2200-6. PubMed ID: 15193680 [TBL] [Abstract][Full Text] [Related]
22. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy. Dahlöf B Blood Press Suppl; 1992; 6():1-75. PubMed ID: 1345261 [TBL] [Abstract][Full Text] [Related]
23. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508 [TBL] [Abstract][Full Text] [Related]
24. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
26. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy. Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B; Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265 [TBL] [Abstract][Full Text] [Related]
27. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431 [TBL] [Abstract][Full Text] [Related]
28. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014 [TBL] [Abstract][Full Text] [Related]
29. [The effect of hypotensive drugs on left ventricular mass and diastolic function]. Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699 [TBL] [Abstract][Full Text] [Related]
30. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164 [TBL] [Abstract][Full Text] [Related]
31. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Jula AM; Karanko HM Circulation; 1994 Mar; 89(3):1023-31. PubMed ID: 8124787 [TBL] [Abstract][Full Text] [Related]
32. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664 [TBL] [Abstract][Full Text] [Related]
33. Serial echocardiographic assessment of left ventricular mass: how blinded should readers be? Gosse P; de Simone G; Dubourg O; Guéret P; Schmieder R J Hypertens; 2004 Sep; 22(9):1813-8. PubMed ID: 15311111 [TBL] [Abstract][Full Text] [Related]
34. Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project. Schneider MP; Klingbeil AU; Delles C; Ludwig M; Kolloch RE; Krekler M; Stumpe KO; Schmieder RE Hypertension; 2004 Jul; 44(1):61-6. PubMed ID: 15184349 [TBL] [Abstract][Full Text] [Related]
35. Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Shibasaki Y; Masaki H; Nishiue T; Nishikawa M; Matsubara H; Iwasaka T Nephron; 2002 Mar; 90(3):256-61. PubMed ID: 11867945 [TBL] [Abstract][Full Text] [Related]
36. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related]
37. Effect of treatment of isolated systolic hypertension on left ventricular mass. Ofili EO; Cohen JD; St Vrain JA; Pearson A; Martin TJ; Uy ND; Castello R; Labovitz AJ JAMA; 1998 Mar; 279(10):778-80. PubMed ID: 9508155 [TBL] [Abstract][Full Text] [Related]
38. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial. Davis BR; Cutler JA; Furberg CD; Wright JT; Farber MA; Felicetta JV; Stokes JD; Ann Intern Med; 2002 Sep; 137(5 Part 1):313-20. PubMed ID: 12204014 [TBL] [Abstract][Full Text] [Related]
39. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. de Simone G; Devereux RB; Izzo R; Girfoglio D; Lee ET; Howard BV; Roman MJ J Am Heart Assoc; 2013 Jun; 2(3):e000144. PubMed ID: 23744404 [TBL] [Abstract][Full Text] [Related]
40. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial. Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]